Search research articles
Contact Us
Filters
Showing results (171-180 of 179) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 179 results.
Journal of Integrative Plant Biology
|
March 14, 2023
Differential SW16.1 allelic effects and genetic backgrounds contributed to increased seed weight after soybean domestication
Xianlian Chen, Cheng Liu, Pengfei Guo, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
November 23, 2020
Blood pressure variability and outcome in acute severe stroke: A post hoc analysis of CHASE-A randomized controlled trial
Jingjing Zhao, Fang Yuan, Feng Fu, et al.
Annals of Clinical and Translational Neurology
|
September 29, 2021
Hypertension management in elderly with severe intracerebral hemorrhage
Jingjing Zhao, Fang Yuan, Feng Fu, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
June 12, 2020
Controlling Hypertension After Severe Cerebrovascular Event (CHASE): A randomized, multicenter, controlled study
Fang Yuan, Fang Yang, Jingjing Zhao, et al.
Cell Reports. Medicine
|
October 4, 2025
Updated efficacy and predictive biomarkers of QL1706, a bifunctional PD-1/CTLA-4 dual blocker in advanced solid tumors-A phase 1/1b study
Yuxiang Ma, Shaoyan Lin, Qun Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2017
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
Christopher J Gibson, R Coleman Lindsley, Vatche Tchekmedyian, et al.
Cancer Cell
|
April 24, 2026
JYP0322, a highly selective and brain-penetrant ROS1 inhibitor, overcomes ROS1<sup>G2032R</sup> resistance mutation in NSCLC: The first-in-human phase 1 trial
Yuxiang Ma, Jinhui Xue, Fangfang Gao, et al.
Journal of Hematology & Oncology
|
May 9, 2023
First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors
Yuanyuan Zhao, Yuxiang Ma, Aimin Zang, et al.
CNS Drugs
|
April 30, 2026
Effect of DL-3-n-Butylphthalide on Cerebral Hypoperfusion Due to Atherosclerotic Stenosis: A Multicenter, Double-Blind, Randomized Controlled, Preliminary Trial
Dawei Chen, Xinxin Chang, Bei Pan, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 179) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 179 results.
Journal of Integrative Plant Biology
|
March 14, 2023
Differential SW16.1 allelic effects and genetic backgrounds contributed to increased seed weight after soybean domestication
Xianlian Chen, Cheng Liu, Pengfei Guo, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
November 23, 2020
Blood pressure variability and outcome in acute severe stroke: A post hoc analysis of CHASE-A randomized controlled trial
Jingjing Zhao, Fang Yuan, Feng Fu, et al.
Annals of Clinical and Translational Neurology
|
September 29, 2021
Hypertension management in elderly with severe intracerebral hemorrhage
Jingjing Zhao, Fang Yuan, Feng Fu, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
June 12, 2020
Controlling Hypertension After Severe Cerebrovascular Event (CHASE): A randomized, multicenter, controlled study
Fang Yuan, Fang Yang, Jingjing Zhao, et al.
Cell Reports. Medicine
|
October 4, 2025
Updated efficacy and predictive biomarkers of QL1706, a bifunctional PD-1/CTLA-4 dual blocker in advanced solid tumors-A phase 1/1b study
Yuxiang Ma, Shaoyan Lin, Qun Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2017
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
Christopher J Gibson, R Coleman Lindsley, Vatche Tchekmedyian, et al.
Cancer Cell
|
April 24, 2026
JYP0322, a highly selective and brain-penetrant ROS1 inhibitor, overcomes ROS1<sup>G2032R</sup> resistance mutation in NSCLC: The first-in-human phase 1 trial
Yuxiang Ma, Jinhui Xue, Fangfang Gao, et al.
Journal of Hematology & Oncology
|
May 9, 2023
First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors
Yuanyuan Zhao, Yuxiang Ma, Aimin Zang, et al.
CNS Drugs
|
April 30, 2026
Effect of DL-3-n-Butylphthalide on Cerebral Hypoperfusion Due to Atherosclerotic Stenosis: A Multicenter, Double-Blind, Randomized Controlled, Preliminary Trial
Dawei Chen, Xinxin Chang, Bei Pan, et al.
Page
of 18